Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can teaching doctors about HPV boost vaccine rates?

NCT ID NCT05120869

Knowledge-focused Sponsor: University of Texas, El Paso Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 26, 2026 · Updated 5 times

Summary

This study tested whether training healthcare providers on HPV and its vaccine improves their knowledge, attitudes, and communication with patients. Researchers recruited 178 providers in the El Paso border region and compared two types of education programs. The goal was to see if better provider training could reduce vaccine hesitancy and increase HPV vaccine uptake in the community.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this approach could help more people get the HPV vaccine and reduce HPV-related cancers in the community.
What could go wrong
This is a completed behavioral study with 178 providers in one region, so results may not apply to other areas or directly prove increased vaccination.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

161 people

The number who actually took part.

Started

Dec 2023

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Current (in practice) or emerging (in training - medical student, resident, or fellow) healthcare provider * Working/training or living in the El Paso U.S.-Mexico Border Region (i.e., El Paso County, TX-Southern New Mexico) * Have the authorization to recommend/prescribe/administer the HPV vaccine Exclusion Criteria: * Unaffiliated with the El Paso U.S.-Mexico Border Region (i.e., El Paso County, TX-Southern New Mexico) * Participation in Phases I or II of the larger research project \[cross-sectional phases\] * Does not identify as a current or emerging healthcare provider * Declines or is unable to participate in the full intervention and follow-up time-points * Unable to complete participation and activities in the English language

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Health knowledge, attitudes, practice are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavior Coitus COVID-19 human papilloma virus infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Health knowledge, attitudes, practice Health personnel attitude

Contacts and locations

Locations

  • Burrell College of Osteopathic Medicine

    Las Cruces, New Mexico, 88001, United States

  • The University of Texas at El Paso, Border Biomedical Research Center

    El Paso, Texas, 79968, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.